Where is Heidi Health headquartered?

Heidi Health is headquartered in Melbourne, Australia. The company has a team of 200+ people.

What does Heidi Health do?

Heidi Health operates in the AI in Healthcare sector. AI medical scribe platform that automates clinical documentation and administrative tasks for clinicians Reduces administrative burden for clinicians by 30-50%, saves 18M+ hours of documentation time, and improves patient care through AI-driven automation

When was Heidi Health founded?

Heidi Health was founded in 2019. It is based in Melbourne, Australia.

Who is the CEO of Heidi Health?

Dr. Thomas Kelly is the CEO of Heidi Health. The company was founded in 2019.

Where is Heidi Health located?

Heidi Health is headquartered in Melbourne, Australia.

What funding stage is Heidi Health at?

Heidi Health is currently at the Scaling stage.

How many employees does Heidi Health have?

Heidi Health has approximately 200+ employees.

Heidi Health

Category: AI in Healthcare

AI medical scribe platform that automates clinical documentation and administrative tasks for clinicians Heidi Health was founded in 2019. The company is led by Dr. Thomas Kelly. Based in Melbourne, Australia. Team size: 200+. Total funding raised: $96.6M. Latest round: Series B. Key investors include ["Point72 Private Investments","Blackbird Ventures","Headline","Latitude","Archangel Ventures","Possible Ventures","January Capital"].

Founded: 2019
Headquarters: Melbourne, Australia
Team size: 200+
Total funding: $96.6M

Value proposition

Reduces administrative burden for clinicians by 30-50%, saves 18M+ hours of documentation time, and improves patient care through AI-driven automation

Products and solutions

["AI Medical Scribe (ambient transcription and note-taking)","Pre-chart summaries","Clinical guideline lookups","Automated form filling","Patient outreach tools","EHR integration","Heidi Evidence (clinical decision support with citations)","Heidi Comms (AI-powered patient communications)","Heidi Remote (wearable offline mic)"]

Unique value

Focus on user-centric customization with templates matching clinicians' styles, global scalability from day one, and seamless ambient AI workflows avoiding clunky EHR integrations

Target customer

Clinicians, GPs, hospitals, and healthcare systems including NHS Trusts, Beth Israel Lahey Health, and Australian health systems

Industries served

["Primary care","Hospital systems","Telehealth","Mental health","Allied health","Veterinary medicine","Global healthcare (UK NHS, US, Australia, New Zealand, Canada)"]

Technology advantage

Proprietary AI model with real-time transcription engine optimized for clinical jargon, HIPAA-grade cloud architecture, and multilingual natural-language understanding trained on millions of clinical dialogue snippets

How they differentiate

Heidi differentiates through ambient listening technology and end-to-end automation of clinical documentation, with proprietary real-time transcription optimized for clinical jargon, whereas competitors rely on legacy speech engines or fragmented integrations

Main competitors

["DeepScribe","Ambience Healthcare","Abridge","Nuance Dragon Medical","Suki","Robin Healthcare"]

Key partnerships

["Vim (EHR integration)","NHS Innovation Fund","Point72 Private Investments","Blackbird Ventures","Headline","Latitude","Best Practice Software","R1 RCM (revenue cycle management)","HealthPathways","EMGuidance","MIMS","Vidal","NICE","BMJ Group","Anthropic (Claude models for Evidence)"]

Notable customers

["NHS (National Health Service)","Beth Israel Lahey Health","MaineGeneral Health","Monash Health","Queensland Health Children's Hospital","Yukon Government","Eucalyptus","Icon Group","Cabrini Health","Mater Health"]

Major milestones

["$65M Series B funding in October 2025","18 million hours returned to frontline clinicians","100M+ clinical interactions globally","2.4M+ weekly consults across 190 countries","Recognition as Becker's Health IT & Revenue Cycle Up-and-Comer for 2025","Launch of Heidi Evidence and Heidi Comms (Feb 2026)","Acquisition of UK-based AutoMedica (Feb 2026)","Strategic partnership with R1 RCM (March 2026)","$50M ARR milestone (April 2026)","$660M valuation (April 2026)"]

Growth metrics

18M+ hours returned to clinicians, 100M+ clinical interactions globally, 2.4M+ weekly consults across 110 languages in 190 countries, serving clinicians in 50+ countries

Market positioning

Positioned as an AI 'care partner' for clinicians globally, focusing on both private clinics and public healthcare providers with emphasis on making core features free and self-serve onboarding

Geographic focus

Primary markets in Australia (headquarters), United States, United Kingdom, and Canada, with expansion into European healthcare systems through NHS partnerships

Patents and IP

No publicly disclosed patents; innovation is primarily in proprietary AI workflows and user experience design

About Dr. Thomas Kelly

Former vascular surgical resident with expertise in medical AI and healthcare innovation. Previously co-founded Oscer (AI medical training platform) and has background in mathematics and deep learning.

Official website: https://www.heidihealth.com